Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/1998
12/10/1998WO1998055145A1 Herpes simplex virus vp22 vaccines and methods of use
12/10/1998WO1998054963A2 207 human secreted proteins
12/10/1998WO1998039465A3 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
12/10/1998WO1998039429A3 Compositions for treatment of disorders involving programmed cell death
12/10/1998WO1998038325A3 Retroviral vectors, method for the production and the use thereof for gene transfer in cd4-positive cells
12/10/1998WO1998036059A3 Prion propagation inhibition by dominant-negative prion protein mutants
12/10/1998WO1998033478A3 Rna- and dna-based active agents in nanoparticles
12/10/1998CA2293693A1 Anti-gpiib/iiia recombinant antibodies
12/10/1998CA2292899A1 Ntn-2 member of tnf ligand family
12/10/1998CA2292838A1 Lactoferrin receptor genes of moraxella
12/10/1998CA2292837A1 Novel class of nucleic acid cationic transfecting agents
12/10/1998CA2292835A1 Ntn-2 member of tnf ligand family
12/10/1998CA2292760A1 Vector
12/10/1998CA2291862A1 New selection marker
12/10/1998CA2291260A1 207 human secreted proteins
12/10/1998CA2291010A1 Herpes simplex virus vp22 vaccines and methods of use
12/10/1998CA2289479A1 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
12/10/1998CA2262388A1 23s rna nucleotide fragment of the clhamydia genus bacteria, uses as probe, primer, and in a reagent and a detection and a detection method
12/10/1998CA2234411A1 Novel compounds
12/09/1998EP0882795A2 Recombinant secA1 polypeptides from Staphylococcus aureus and uses thereof
12/09/1998EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998EP0882791A2 WNT-11 polypeptides
12/09/1998EP0882228A1 Methods to identify modulators of cell signaling
12/09/1998EP0882134A1 Methods and compositions for protective and therapeutic genetic immunization
12/09/1998EP0882130A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
12/09/1998EP0882065A2 Novel human metabotropic glutamate receptor
12/09/1998EP0881914A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression
12/09/1998EP0881913A1 Liposomal-viral dna complexes for treating disease
12/09/1998EP0881906A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants
12/09/1998EP0881884A1 Bacterial delivery system
12/09/1998EP0636028A4 Self-assembling polynucleotide delivery system.
12/09/1998EP0332667B2 Vector for integration site independent gene expression in mammalian host cells
12/09/1998CN1201492A Cell-cycle checkpoint genes
12/09/1998CN1201369A Stimulation of cell-mediated immune responses by targeted particulated genetic immunization
12/09/1998CA2231015A1 Novel compounds
12/08/1998US5847096 DNA constructs encoding CD4 fusion proteins
12/08/1998US5847083 Modified p53 constructs which enhance DNA binding
12/08/1998US5846948 Herpes simplex virus ORF P is a repressor of viral protein synthesis
12/08/1998US5846947 Composition containing nucleic acids, preparation and uses
12/08/1998US5846946 Compositions and methods for administering Borrelia DNA
12/08/1998US5846945 Cytopathic viruses for therapy and prophylaxis of neoplasia
12/08/1998US5846825 Feline derived T-cell lines for producing FIV
12/08/1998US5846806 Identification of a human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression
12/08/1998US5846782 Targeting adenovirus with use of constrained peptide motifs
12/08/1998US5846780 Murine RATH gene
12/08/1998US5846773 Single gene encoding aortic-specific and striated-specific muscle cell isoforms and uses thereof
12/08/1998US5846725 Methods for identifying cisplatin resistant tumor cells
12/08/1998US5846720 Methods of determining chemicals that modulate expression of genes associated with cardiovascular disease
12/08/1998US5846712 Tumor suppressor gene, HIC-1
12/08/1998US5846528 Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
12/08/1998US5846225 Gene transfer therapy delivery device and method
12/08/1998CA2073180C Therapeutic uses of melanin
12/04/1998CA2233587A1 Novel compounds
12/03/1998WO1998054547A1 Magnetic rotation sensor
12/03/1998WO1998054366A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
12/03/1998WO1998054365A1 Control of immune responses by modulating activity of glycosyltransferases
12/03/1998WO1998054348A1 Telomere-associated chromosome fragmentation
12/03/1998WO1998054347A1 Integrin-targeting vectors having transfection activity
12/03/1998WO1998054346A1 Alternatively targeted adenovirus
12/03/1998WO1998054345A1 Mini-adenoviral vector
12/03/1998WO1998054322A1 Osf2/cbfa1 compositions and methods of use
12/03/1998WO1998054318A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
12/03/1998WO1998054313A2 Dna methyltransferase genomic sequences and antisense oligonucleotides
12/03/1998WO1998054311A1 Zinc finger protein derivatives and methods therefor
12/03/1998WO1998054310A2 Methods for activating inactive genes and methods for altering the rate of development of cells, tissues and organisms
12/03/1998WO1998054301A2 Transplants for myocardial scars and method and cellular preparations therefor
12/03/1998WO1998054298A1 Overexpression of cardiac receptors for myocardial protection
12/03/1998WO1998054217A1 Angiostatin fragments and method of use
12/03/1998WO1998054216A1 Gene and amino acid sequences for novel transcription factor
12/03/1998WO1998054213A2 Neurotrophic factor receptors
12/03/1998WO1998054212A2 Human type 3 ryanodine receptor protein and dna molecules coding therefor
12/03/1998WO1998054205A1 Selective induction of cell death by delivery of amino-terminal interleukin-1-alpha pro-piece polypeptide
12/03/1998WO1998054203A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
12/03/1998WO1998054130A1 Compounds, preparation and use for transferring nucleic acids into cells
12/03/1998WO1998053854A1 Antigen delivery system
12/03/1998WO1998053853A1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy
12/03/1998WO1998053852A1 P-selectin translocation to vascular epithelial lumen by ionizing radiation
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053804A1 Methods and compositions for targeting compounds to muscle
12/03/1998WO1998045712A3 20 human secreted proteins
12/03/1998WO1998041631A3 β-CATENIN, TCF-4, AND APC INTERACT TO PREVENT CANCER
12/03/1998WO1998040486A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998039427A3 Gene therapy using bone marrow transplants transfected with therapeutic genes under the control of tissue-specific promoters
12/03/1998WO1998033916A3 Secreted proteins and polynucleotides encoding them
12/03/1998CA2291960A1 Human type 3 ryanodine receptor protein and dna molecules coding therefor
12/03/1998CA2291881A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
12/03/1998CA2291861A1 Zinc finger protein derivatives and methods therefor
12/03/1998CA2291698A1 Osf2/cbfa1 compositions and methods of use
12/03/1998CA2291595A1 Dna methyltransferase genomic sequences and antisense oligonucleotides
12/03/1998CA2291590A1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy
12/03/1998CA2291484A1 Gene and amino acid sequences for novel transcription factor
12/03/1998CA2291451A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
12/03/1998CA2291323A1 Alternatively targeted adenovirus
12/03/1998CA2291278A1 Antigen delivery system
12/03/1998CA2290563A1 P-selectin translocation to vascular epithelial lumen by ionizing radiation
12/03/1998CA2288840A1 Integrin-targeting vectors having transfection activity
12/03/1998CA2288235A1 Tumour suppressor gene dbccr1 at 9q32-33
12/02/1998EP0881298A2 Metalloporoteases
12/02/1998EP0881297A2 Histidine kinase
12/02/1998EP0881296A2 Histidine kinase
1 ... 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 ... 870